The Council for Pediatric Vision has approved VisioCheck, Conexus’ comprehensive technology-based children’s vision program, as “best practice” for vision screenings in children through five years of age. This approval is based on existing scientific studies of the equipment combined with years of practical application of the complete program, including the screening and VisioCheck’s exclusive process for communicating results, facilitating follow up, and managing data.
In its desire to expand the best practice recommendation of VisioCheck to include all school-aged children, the Council acknowledged the need for a controlled study to substantiate the five years of program data we have collected through VisioCheck delivery in grades K through 12. The study, managed through VCU Medical Center under the direction of Evan Silverstein, MD, will compare the overall effectiveness of VisioCheck to traditional chart-based screenings in a mass screening environment. While the screening technology is being used throughout the United States, and our own experience and analysis have indicated a significant advantage in efficiency and accuracy, changes to the broad recommendations for mass screenings for school-aged children require definitive evidence of these advantages. This is the first study of its kind to be conducted, and the outcomes are expected to have a substantial influence on vision screening recommendations nationwide.
The foundational work for the study is being finalized. Program activity to support the study is expected to take place in the fall of 2016, with release of the study’s results anticipated in early 2017.
Click here for more information about the Council for Pediatric Vision